Warning Letter – Mediagnost GmbH

Recipient: Mediagnost GmbH.
Product: Human Growth Hormone diagnostic kits
Date: 5/8/12

Failure to establish and maintain adequate procedures to control all documents, as required by 21 CFR 820.40. For example:

a. There are no procedures that address the control of electronic records.

b. Access to two computer workstations that include in-process test data, finished device testing results, and access to the firm’s network were not adequately controlled. The workstations have no access limitation controls or locks, all employees share the same user name and password, and the computers all access the firm’s overall network and records.

We reviewed your firm’s responses and conclude that they are not adequate.

Your firm did not provide a plan or documentation for correction of this observation. Your firm stated that it will evaluate the current electronic data record system and will consider switching to a paper-based system. However, your firm has not supplied any information on its proposed corrective actions.

Issuer: Center for Devices and Radiological Health (CDRH)

Upcoming Training

62304, FDA, and Emerging Standards for Medical Device and HealthIT
Instructors:  Brian Pate, John F. Murray, Jr
Location: Sunnyvale, CA, USA
Dates:  February 4-6, 2020
Registration Link

Receive $300 discount with Premium-Individual subscription purchase (or $333 per person for Premium-Company subscription)!  Email training@softwarecpr.com
to receive discount

QSS Software Validation
Planned Instructors:  Brian Pate, John F. Murray, Jr
Location: Boston, MA, USA
Dates:  June 2-4, 2020
For info on this course, email training@softwarecpr.com

Corporate Office

15148 Springview St
Tampa, FL 33624
Partners located in the US (CA, FL, MA, MN) and Italy.